Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUND)

Market Cap	5.30M -38.4%
Revenue (ttm)	9.60M -21.0%
Net Income	-11.01M
EPS	-13.15
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	6.00
Previous Close	6.00
Day's Range	6.00 - 6.00
52-Week Range	0.06 - 6.00
Beta	n/a
RSI	n/a
Earnings Date	Mar 30, 2026

About TKUND

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers clinical research, training, and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd was founded in 2006 and is based in Nof HaGalil, Israel.

• Industry: Pharmaceutical Preparations
• Founded: 2006
• Employees: 19
• Stock Exchange: OTCMKTS
• Ticker Symbol: TKUND

Financial Performance

In 2024, TKUND's revenue was 34.95 million, a decrease of -20.97% compared to the previous year's 44.23 million. Losses were -40.10 million, -54.88% less than in 2023.

Financial numbers in ILS